Group One Trading
NAVB

Group One Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Group One Trading’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,700
Closed -$6K – 8721
2022
Q2 		$6K Sell
7,700
-9,300
-55% -$7.9K ﹤0.01% 7075
2022
Q1 		$13K Sell
17,000
-700
-4% -$641 ﹤0.01% 7072
2021
Q4 		$18K Sell
17,700
-7,500
-30% -$10.6K ﹤0.01% 7051
2021
Q3 		$44K Sell
25,200
-12,500
-33% -$21K ﹤0.01% 6650
2021
Q2 		$69K Buy
37,700
+25,100
+199% +$44.4K ﹤0.01% 6313
2021
Q1 		$25K Sell
12,600
-36,200
-74% -$84.7K ﹤0.01% 6670
2020
Q4 		$105K Buy
48,800
+37,200
+321% +$87.7K ﹤0.01% 4532
2020
Q3 		$31K Sell
11,600
-3,900
-25% -$14K ﹤0.01% 4924
2020
Q2 		$61K Sell
15,500
-35,800
-70% -$68.5K ﹤0.01% 4239
2020
Q1 		$39K Buy
51,300
+700
+1% +$772 ﹤0.01% 3883
2019
Q4 		$64K Buy
+50,600
New +$43.7K ﹤0.01% 3895
2018
Q1 		– Sell
-2,550
Closed -$18K – 5603
2017
Q4 		$18K Sell
2,550
-400
-14% -$3.38K ﹤0.01% 4194
2017
Q3 		$24K Hold
2,950
– – ﹤0.01% 3994
2017
Q2 		$30K Buy
2,950
+2,550
+638% +$25.2K ﹤0.01% 3787
2017
Q1 		$5K Buy
+400
New +$4.54K ﹤0.01% 4307
2016
Q4 		– Sell
-545
Closed -$10K – 5074
2016
Q3 		$10K Sell
545
-655
-55% -$8.29K ﹤0.01% 4059
2016
Q2 		$13K Hold
1,200
– – ﹤0.01% 3988
2016
Q1 		$23K Sell
1,200
-3,535
-75% -$68K ﹤0.01% 3681
2015
Q4 		$126K Buy
4,735
+640
+16% +$22.2K ﹤0.01% 2839
2015
Q3 		$187K Sell
4,095
-4,645
-53% -$175K ﹤0.01% 2553
2015
Q2 		$281K Buy
8,740
+4,165
+91% +$121K ﹤0.01% 2281
2015
Q1 		$145K Buy
4,575
+4,555
+22,775% +$154K ﹤0.01% 2628
2014
Q4 		$1K Sell
20
-540
-96% -$14.8K ﹤0.01% 4811
2014
Q3 		$15K Buy
560
+360
+180% +$9.53K ﹤0.01% 4278
2014
Q2 		$6K Sell
200
-1,545
-89% -$50K ﹤0.01% 4720
2014
Q1 		$65K Buy
1,745
+950
+119% +$36K ﹤0.01% 3442
2013
Q4 		$33K Sell
795
-4,905
-86% -$192K ﹤0.01% 3950
2013
Q3 		$302K Buy
5,700
+3,850
+208% +$224K 0.01% 2029
2013
Q2 		$99K Buy
+1,850
New +$92.4K ﹤0.01% 2829

Other funds holding NAVB

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Group One Trading's NAVB Position: Q4 2023 in Review

Group One Trading sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2023, closing a stake of 300 shares — an estimated $27 sold.

Group One Trading first reported a position in NAVB in Q2 2013 and held it in 31 quarters. The position peaked at $317K in Q1 2014. 4 funds tracked by Wall St. Rank hold NAVB as of Q4 2023.

  • Group One Trading reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 300 Navidea Biopharmaceuticals Inc. shares in Q4 2023, an estimated $27.
  • Group One Trading first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 31 quarters.
  • Group One Trading's Navidea Biopharmaceuticals Inc. position peaked at $317K in Q1 2014.
  • 4 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.